MAY & BAKER NIGERIA PLC released it audited financial accounts for the year 2017. Please find attached the full result of MAY & BAKER NIGERIA PLC as released on the NSE and see key highlights below:
- Revenue grew by 10.43% to N9.35bn from N8.47bn. The pharmaceutical segment of the firm recorded a growth of 26.94% in 2017.
- Cost of sales was up marginally by 2.39% to N6.08bn as the gross margin improved to 35% from 30% achieved in 2016
- The finance costs rose significantly by 37% to N682mn from N519mn.
- Profit after Tax grew by 800% to N370.86mn in 2017
Proposed Dividend 20kobo
Qualification date 20th April 2018
Closure Date 23rd – 27th April 2018
Payment Date 6th June 2018